CLINICAL_TRIALS
trial_result
· 2017-09-06
Clinical Trial Update: Role of Aromatase Inhibitor to Enhance Ovulation in Poor Responder During Induction With Short Antagonist Protocol in Cases of ICSI [Phase 4]
Summary
Phase 4 trial evaluating the role of an aromatase inhibitor to enhance ovulation in poor responders undergoing induction with a short antagonist protocol for IC…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Minia University | Conditions: Infertility Indicated for ICSI | Phase 4 | Status: COMPLETED